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Abstract
Biomedical journals continue to be the single most important conduit for disseminating biomedical knowledge.
Unlike clinical medicine, where evidence is considered fundamental to practice, journals still operate largely in a
‘black box’ mode without sufficient evidence to drive their practice. We believe there is an immediate need to
substantially increase the amount and quality of research by journals to ensure their practice is as evidence based
as possible. To achieve this goal, we are proposing the development of an international ‘best practice journal
research network’. We invite journals and others to join the network. Such a network is likely to improve the quality
of journals. It is also likely to address many unanswered questions in publication science, including peer review,
which can provide robust and generalizable answers.
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Background
Biomedical journals remain the central conduit through
which biomedical knowledge is disseminated; this is likely
to continue for the foreseeable future regardless of the
publishing models used for dissemination. However, even a
cursory scan of what journals publish raises concern – the
quality of reporting of peer-reviewed and editor-approved
clinical and preclinical research is appalling [1–5]. If reports
of clinical research are unusable, this substantially reduces
the confidence clinicians have in using best evidence to in-
form best practice, therefore affecting patient care directly.
The reasons behind the poor completeness of reporting
of biomedical research are complex and involve various
players - publishers, journals, and scientific editors are
partially responsible. For example, editors do not explicitly
recommend the use of reporting guidelines as part of the
review process [6] despite emerging evidence indicating
that their use is associated with more complete reporting
[7, 8]. Further, there appears to be a knowledge gap for
scientific editors and peer reviewers [9]; more than a third
of manuscripts submitted to 46 journals for publication
consideration were inappropriately classified by the edi-
torial offices as randomized trials during a study [10].
Additionally, there is still no agreement regarding the
effectiveness of peer review. Unlike clinical medicine,
where evidence is considered fundamental to practice,
journals still operate largely in a ‘black box’ mode without
sufficient evidence to drive their practice.
Innovative editors have not stood still. In 1989, cham-
pioned by Drummond Rennie and JAMA, the first Inter-
national Congress on Peer Review and Biomedical
Publication was held, its remit being to investigate and
better understand the scientific process of publication. The
congress, held every 4 years, and jointly coordinated with
the BMJ, is an important oracle for sharing journalology
[11] research. The eighth congress will be held in Chicago
in 2017 [12]. Likewise, in 1994, Richard Smith, editor-in-
chief of BMJ established Locknet, its remit being the focus
on research issues related to the peer review process [13].
Locknet is not currently active (Richard Smith, personal
communication), although the BMJ and JAMA both have a
long tradition of collaborative journalology research.
The evidence base underlying journalology is too small
and consists largely of descriptive studies and few
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observational and quasi-experimental studies [14]. An
underwhelming number of randomized trials [14] have ad-
dressed ‘what works’ questions in journalology and in a re-
lated field of investigation, research on research (i.e., meta-
research) [15]. Therefore, we are interested in finding ways
to substantially increase the amount of research conducted
by journals in journalology and meta-research. We believe
there are models in clinical medicine that could be success-
fully adapted for journals to develop and sustain an in-
ternational biomedical journal research network (http://
or.org/pdf/NIH_Roadmap-ClinicalResearch.pdf). Similarly,
the Army of Women (https://www.armyofwomen.org/) has
proven to be an effective model to increase participation in
breast cancer trials. This might be a useful model to
consider in order to ensure the participation of sufficient
journals in journalology research.
It is likely that many journal editors have limited
experience in participating in research studies and may
feel they lack the expertise to conduct and participate in
such studies. Therefore, we think that any journal want-
ing to join the network should ‘buddy’ with an estab-
lished research team involved in this domain. Journals
are best placed to consider how such an arrangement
might work optimally and the arrangements might differ
across journals; one option to consider is appointing a
member of the clinical research team as a member of a
journal’s scientific editorial team (http://eyes.cochra-
ne.org/partnerships-eyes-and-vision-journals).
Journals might be interested in joining the network, and
conducting and participating in research, for a variety of
reasons – it is likely the best way of improving the quality
of their journal (clinical centres participating in research
provide better care and participants have better outcomes)
[16]; it would enhance journal personnel expertise and ex-
perience in research, including clinical trials, which in turn
might also help them review similar submissions to their
journals; and it would help to more reliably answer relevant
questions about journalology.
A journal research network can play an important role
in enhancing the science of journalology and meta-
research. Many researchers have addressed questions
around whether peer review is effective. To date, there is
no clear definitive answer. Too few studies have been con-
ducted and, of those published, there is little agreement
about optimal designs [17] and best primary outcome(s).
Our community might benefit from experiences in clinical
medicine by developing core outcome sets across a range
of journalology topics, including peer review, and par-
ticipating in the COMET initiative [18]. Similarly, we
might benefit from involving members of the public
and other advocacy groups in our research, following
similar developments in clinical medicine.
We have discussed the idea of developing a network of
journals for conducting research with a few colleagues in
leadership positions at several journals (see Acknowledge-
ments). These journals have welcomed this development
and have agreed to help establish the initiative. While edi-
tors are crucial to help ensure the development and success
of the network, other groups are also needed. Perhaps edi-
tors can promote the network to their publishers. Pub-
lishers bring an important cultural and policy authority to
the table; they can be a powerful voice in enabling new per-
spectives such as data sharing. Similarly, they will be an im-
portant voice in taking new evidence generated from the
network and implementing best practices in their jour-
nal(s). Funders of biomedical research are also important to
include in the network. Their investment in research has
often resulted in substantial waste in the form of unusable
publications [19]. It is safe to assume their interests lie in
increasing the research value of their investments, ensuring
the public’s funding of research is being used optimally.
By joining the network, journals commit to engage in dis-
cussions about ways to improve the quality of published re-
search. Since this initiative is new, it is difficult to be more
precise as to how the network will evolve and mature over
time. However, for the immediate future, the practical goals
are to meet virtually, gauge interest in developing audit and
feedback mechanisms to monitor the quality of journal
publications, and provide opportunities for journals to par-
ticipate in various research projects. The primary remit of
the network is to substantially increase the amount of re-
search, including clinical trials, addressing relevant ques-
tions in journalology. We invite journals to join the “Best
Practice Journal Research Network” by completing a simple
registration form (http://www.bpjrn.com/). An important
outcome of this increased activity will be to provide more
data and robust research to inform an evidence-based ap-
proach to running the scientific aspects of journals.
There is still a large number of unanswered questions
that research can provide robust and generalizable answers
to (Box 1). We know there are many other questions
that need to be answered and we invite others to
Box 1
1. Does scientific editor training in core competencies result in
more use of reporting guidelines by journal editors and peer
reviewers?
2. Do reporting guidelines improve the completeness of
reporting observational studies?
3. Does a formal assessment of clinical trial protocols during
peer review of completed trial reports reduce switched
outcomes when these reports are published?
4. Does better peer review reduce the number of retractions?
Moher and Ravaud BMC Medicine  (2016) 14:154 Page 2 of 4
submit questions to the network website. This can provide
a venue to refine the research question and proposed
methodology, and to conduct and report such research
optimally. Similarly, in clinical medicine, multi-centre
research often provides greater generalizability of the re-
sults. While conducting research at a single journal is a
good starting point, we believe such research is more
generalizable when conducted across multiple journals.
We think a network of journals working together will in-
crease the number of multi-centre studies in journalology.
Recognizing the importance of access to data for bio-
medical research, editorial groups are now advocating
for this in clinical medicine [20, 21]. Editors and pub-
lishers also need to strongly advocate for data sharing to
help promote research within their own community. For
example, several questions concerning peer review can
only be meaningfully answered with access to journal
peer review reports. By analogy to clinical data, we think
that publicly funded peer review (many researchers are
publicly funded) data are a public good, produced in the
public interest, and that they should be openly available
to the maximum extent possible. While access is pos-
sible in some open access journals, all journals need to
develop a mechanism to ensure access to all of their
peer review reports. It would be unfortunate to advocate
for data sharing in clinical medicine and neglect similar
needs of journalology researchers.
How might a journal research network move forward?
One possibility is to use a template similar to that
successfully used by the Committee on Publication Eth-
ics. We have started the network with the development
of a website. We hope this will facilitate international
outreach, such as to the Counsel of Science Editors, Asia
Pacific Association of Medical Journal Editors, and other
groups and interested individuals. A few of the network
ideas possibly overlap with those of the Responsible
Research and Innovation movement [22]. Links to this
group and others is also important to pursue.
We hope publishers, editors, funders, and others
will join the network. The small group of editors ini-
tially approached will speak shortly and will reach out
more broadly thereafter. Like any new initiative, we
will have to work hard to keep the network practical
and of interest to a very broad spectrum of editors
and publishers, and funding opportunities will need
to be sought to facilitate the initial development of
the network and sustain it. Journals participating in
research will also need intellectual and fiscal support
to participate in research studies.
Journals need best evidence to inform their best prac-
tice, which will increase confidence in how journals
function as well as help reduce the enormous waste in
the system. We invite interested journals and their pub-
lishers to join us on this adventure.
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